4Q FY 2025 Earnings Call March 10, 2026 Agenda 01 Business Update Ameet Mallik Chief Executive Officer 02 Financial Update Pepe Carmona Chief Financial Officer 03 Q&A 2 Forward-Looking Statements This presentation and any accompanying oral presentation have been prepared by ADC Therapeutics SA ("ADC Therapeutics", "we" or "us") for informational purposes only and not for any other purpose. Nothing contained in this presentation is, or should be construed as, a recommendation, promise or representation by th ...

2nd Quarter Fiscal 2026 March 10, 2026 Disclaimer Certain information in this presentation and discussed on the conference call which this presentation accompanies constitutes forward-looking information within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this presentation regarding the Company's business that are not historical facts are "forward-looking statements" that involve risks and uncertainties and are based on current expectations and management estimates; act ...

Fourth Quarter 2025 Earnings MARCH 10, 2026 Safe Harbor / Non-GAAP Financial Disclosures Forward-Looking Statements This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements regarding our business strategy, plans and objectives and our expected or contemplated future operations, results, financial condition, beliefs and intentions. In addition, any statements t ...

Committed to solid profitable growth Investor Introduction March 2026 Presentation Titel Forward looking and intended use statements Safe Harbor Statement: Certain statements contained in this presentation may be considered forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. These statements can be identified by the use of forward-looking terminology such as "believe", "hope", "p ...

This presentation contains statements that may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including those related to the expectations for future periods, possible or assumed future results of operations, financial conditions, liquidity and related sources or needs, business and/or integration strategies, plans and synergies, supply chain, growth opportunities, and performance at our stores. There are a number of known and unknown risks, ...

Fourth Quarter 2025 Earnings Presentation March 2026 Important notice Cautionary Note Regarding Forward-Looking Statements and Projections. Certain statements in this presentation may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, each as amended. Forward-looking statements provide current expectations of future events and include any statemen ...

Q4 2025 Earnings Call March 10, 2026 Disclaimer This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and 21E of the Securities Exchange Act of 1934, as amended, which provides a "safe harbor" for such statements in certain circumstances. When used in this presentation, the words "anticipates," "may," "believes," "expects," "intends," "plans," "estimates," "predicts," the negative expressions of such words, or similar expressions a ...

Patient Focused. Discovery Driven. Accelerating personalized medicine in autoimmune disease Q4 & FY 2025 UPD ATE | MARCH 10, 20 26 Disclaimer 2 Identifying autoimmune disease is a challenge… Ambiguous symptoms Manifestations overlap Tests lack specificity, sensitivity Outdated tech, testing delays High rate of misdiagnosis With rheumatoid arthritis2 ~1M Americans diagnosed with lupus1 ~2M >41M A M E R I C A N S A N A + ANA+: antinuclear antibody positive, first-line screen for autoimmune disease 3 3 1. lupu ...

Fourth Quarter and Full Year 2025 Forward-looking statements involve inherent risks and uncertainties. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statements. Such risk factors include, but are not limited to, the following: Investors should carefully consider these risk factors, other risk factors described herein, and the additional risk factors outlined in more detail in our 2024 Form 10-K, filed with the Securities and Exchang ...

2026 Investor Day Empowering Consumers with a Scalable Ecosystem March 10 | New York City 2026 INVESTOR DAY 1 Welcome and Opening Remarks John A. Baugh, CFA VP, Investor Relations 2026 INVESTOR DAY 2 Forward Looking Statements Statements in this presentation regarding PROG Holdings, Inc.'s (the "Company") businesses, operations and performance that are not historical facts are "forward-looking statements" that involve risks and uncertainties which could cause actual results to differ materially from those c ...